文献速递甲状腺疾病肥胖与代谢综合征

老年人血清促甲状腺激素水平与代谢性疾病的关系

Relationship Between Serum Thyrotropin Levels and Metabolic Diseases in Older Adults.
PubMed 文献 · J Clin Endocrinol Metab · 2025-01-01

这项横断面研究从中国大陆31个省份具有全国代表性的普通社区抽样,纳入6791名老年人(≥65岁)和55303名年轻人(18-64岁),排除显性甲亢或显性甲减者。老年人中促甲状腺激素(TSH)轻度升高组(4.21-8.86 mU/L)相比甲状腺功能正常组(0.27-4.2 mU/L)未显著增加所评估代谢紊乱的患病率;校正干扰因素后,TSH高于8.86 mU/L是高密度脂蛋白胆固醇偏低(OR 1.84;95% CI 1.14-2.98)和血脂异常(OR 1.49;95% CI 1.09-2.04)的独立危险因素。作者据此推荐提高65岁及以上人群的TSH范围上限。

要点

  • 老年人TSH轻度升高(4.21-8.86 mU/L)相比甲状腺功能正常组,所评估代谢紊乱患病率无显著增加。
  • 老年人TSH高于8.86 mU/L与高密度脂蛋白胆固醇偏低(OR 1.84;95% CI 1.14-2.98)独立相关。
  • 老年人TSH高于8.86 mU/L与血脂异常(OR 1.49;95% CI 1.09-2.04)独立相关。

核心结论

  • 老年人TSH轻度升高与代谢性疾病风险增加无关,作者建议提高65岁及以上人群的TSH范围上限。

研究设计与样本

  • 横断面研究,从中国大陆31个省份具有全国代表性的普通社区抽样。
  • 排除显性甲亢或显性甲减后,纳入6791名老年人(≥65岁)和55303名年轻人(18-64岁)。
  • 按试剂盒TSH参考范围(0.27-4.2 mU/L)及先前制定的年龄特异性TSH范围(老年人上限8.86 mU/L,年轻人上限6.57 mU/L),将老年人和年轻人分别按TSH水平分为4组。

主要发现

  • 老年人中TSH轻度升高组(4.21-8.86 mU/L)相比甲状腺功能正常组(0.27-4.2 mU/L),所评估代谢紊乱的患病率无显著增加。
  • 校正干扰因素后,老年人中TSH高于8.86 mU/L相比甲状腺功能正常组,是高密度脂蛋白胆固醇偏低的独立危险因素(OR 1.84;95% CI 1.14-2.98)。
  • 校正干扰因素后,老年人中TSH高于8.86 mU/L相比甲状腺功能正常组,是血脂异常的独立危险因素(OR 1.49;95% CI 1.09-2.04)。

关键数值与推荐

  • 试剂盒TSH参考范围为0.27-4.2 mU/L。
  • 年龄特异性TSH范围上限:老年人为8.86 mU/L,年轻人为6.57 mU/L。

临床怎么用

  • 作者推荐提高65岁及以上人群的TSH范围上限。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Subclinical hypothyroidism is associated with metabolic diseases; however, it remains controversial in older individuals. OBJECTIVE: This work aimed to investigate the relationship between thyrotropin (TSH) levels and metabolic diseases. METHODS: In this cross-sectional study, sampling was conducted from nationally representative general communities from 31 provinces in mainland China. A total of6791 older (aged ≥65 years) and 55 303 young participants (aged 18-64 years) were selected after excluding individuals with overt hyperthyroidism or overt hypothyroidism. According to the kit, TSH reference range (0.27-4.2 mU/L) and the age-specific TSH range previously formulated (an upper limit of 8.86 mU/L for older adults and 6.57 mU/L for young adults), the older adults and young adults were separately divided into 4 groups based on their TSH levels. Main outcome measures included anthropometric assessments, serum concentrations of thyroid functions, and various metabolic parameters. RESULTS: In contrast to young adults, there was no significant increase in the prevalence of any metabolic disorders assessed in the slightly elevated TSH group (TSH 4.21-8.86 mU/L) compared to the euthyroid group (TSH 0.27-4.2 mU/L) among older adults. After adjusting for interference factors, a TSH level higher than 8.86 mU/L was found to be an independent risk factor for low high-density lipoprotein cholesterol (OR, 1.84; 95% CI, 1.14-2.98) and dyslipidemia (OR, 1.49; 95% CI, 1.09-2.04) when compared to the euthyroid group in older adults. CONCLUSION: Slightly elevated TSH levels are not associated with an increased risk of metabolic diseases in older adults. Therefore, we recommend raising the upper limit of the TSH range for individuals aged 65 years and older.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Zhai X, Li Y, Teng X, et al. Relationship Between Serum Thyrotropin Levels and Metabolic Diseases in Older Adults. J Clin Endocrinol Metab. 2025. PMID: 38953766. doi:10.1210/clinem/dgae387

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。